Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

ABUS holding history

Arbutus Biopharma Corp in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABUS overviewAll 13F holders of ABUSFull Q2 2026 holdings

Shares (Q2 2026)
27,536
Value
$132.2K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ABUS by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202627,536$132.2K<0.1%−3,015−9.9%ReducedHolders
Q1 202630,551$137.5K<0.1%−5,610−15.5%ReducedHolders
Q4 202536,161$173.9K<0.1%+3,446+10.5%AddedHolders
Q3 202532,715$148.5K<0.1%−5,480−14.3%ReducedHolders
Q2 202538,195$118.0K<0.1%−1,977−4.9%ReducedHolders
Q1 202540,172$140.2K<0.1%−9,949−19.8%ReducedHolders
Q4 202450,121$163.9K<0.1%+11,359+29.3%AddedHolders
Q3 202438,762$149.2K<0.1%+10,144+35.4%AddedHolders
Q2 202428,618$88.4K<0.1%−5,897−17.1%ReducedHolders
Q1 202434,515$89.0K<0.1%+2,829+8.9%AddedHolders
Q4 202331,686$79.2K<0.1%+4,516+16.6%AddedHolders
Q3 202327,170$55.2K<0.1%+188+0.7%AddedHolders
Q2 202326,982$62.1K<0.1%+2,763+11.4%AddedHolders
Q1 202324,219$73.4K<0.1%−3,339−12.1%ReducedHolders
Q4 202227,558$64.2K<0.1%+3,043+12.4%AddedHolders
Q3 202224,515$47.0K<0.1%+802+3.4%AddedHolders
Q2 202223,713$64.0K<0.1%−7,367−23.7%ReducedHolders
Q1 202231,080$93.0K<0.1%−5,519−15.1%ReducedHolders
Q4 202136,599$142.0K<0.1%+5,122+16.3%AddedHolders
Q3 202131,477$135.0K<0.1%−6,103−16.2%ReducedHolders
Q2 202137,580$114.0K<0.1%+25,830+219.8%AddedHolders
Q1 202111,750$39.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.